MSB 2.17% $1.13 mesoblast limited

Ann: Key Day 100 Survival Results In P3 GvHD Trial, page-8

  1. 2,505 Posts.
    lightbulb Created with Sketch. 36
    Tho; interestingly the market so far is reacting like this isn't big news. Call me biased, but I do think that it really is very big news. MSB thinks so too - otherwise they wouldn't announce that they'll request accelerated approval from the FDA.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.